Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
George S. Yacoubian. (2003) Correlates of ecstasy use among high school seniors surveyed through Monitoring the Future. Drugs: Education, Prevention and Policy 10:1, pages 65-72.
Read now
Read now
BlakeJ. Urbach, K.
Michael Reynolds & GeorgeS. Yacoubian$suffix/text()$suffix/text(). (2002) Exploring the Relationship Between Race and Ecstasy Involvement Among a Sample of Arrestees. Journal of Ethnicity in Substance Abuse 1:4, pages 49-61.
Read now
Read now
GeorgeS. Yacoubian. (2002) Correlates of Ecstasy Use Among Tenth Graders Surveyed through Monitoring the Future. Journal of Psychoactive Drugs 34:2, pages 225-230.
Read now
Read now
GeorgeS. Yacoubian, AmeliaM. Arria, Elisabeth Fost & EricD. Wish. (2002) Estimating the Prevalence of Ecstasy Use Among Juvenile Offenders. Journal of Psychoactive Drugs 34:2, pages 209-213.
Read now
Read now
GregoryN. Hayner. (2002) MDMA Misrepresentation: An Unresolved Problem for Ecstasy Users. Journal of Psychoactive Drugs 34:2, pages 195-198.
Read now
Read now
ShanthaM. W. Rajaratnam, JenniferR. Redman & MichaelG. Lenné. (2000) Intoxication and criminal behaviour. Psychiatry, Psychology and Law 7:1, pages 59-69.
Read now
Read now
Stefanie Iwersen & Achim Schmoldt. (1996) Two Very Different Fatal Cases Associated with the Use of Methylenedioxyethylamphet-amine (MDEA): Eve as Deadly as Adam. Journal of Toxicology: Clinical Toxicology 34:2, pages 241-244.
Read now
Read now
F.T. Noggle$suffix/text()$suffix/text(), C.
Randall Clark, Paula Pitts-monk & Jack
De Ruiter. (1991) Liquid Chromatographic and Mass Spectral Analysis of 1-Phenyl-2-Butanamines: Homologues of the Amphetamines. Journal of Liquid Chromatography 14:7, pages 1393-1408.
Read now
Read now
F.T. Noggle$suffix/text()$suffix/text(), C.
Randall Clark, Paula Pitts-monk & Jack
De Ruiter. (1991) Liquid Chromatographic and Mass Spectral Analysis of 1-Phenyl-3-Butanamines: Homologues of the Amphetamines. Journal of Liquid Chromatography 14:3, pages 557-571.
Read now
Read now
C.
Randall Clark, AllenK. Valaer & WilliamR. Ravis. (1990) Liquid Chromatographic Determination of N-Hydroxy-3,4-Methylenedioxyamphetamine and Metabolite in Plasma. Journal of Liquid Chromatography 13:7, pages 1375-1385.
Read now
Read now
PhilipE. Wolfson. (1986) Meetings at the Edge with Adam: A Man for All Seasons?. Journal of Psychoactive Drugs 18:4, pages 329-333.
Read now
Read now
Articles from other publishers (66)
James R. Docherty & Hadeel A. Alsufyani. (2021) Pharmacology of Drugs Used as Stimulants. The Journal of Clinical Pharmacology 61:S2.
Crossref
Crossref
James R. Docherty & Hadeel A. Alsufyani. (2021) Cardiovascular and temperature adverse actions of stimulants. British Journal of Pharmacology 178:13, pages 2551-2568.
Crossref
Crossref
Maria A. Aguilar, Maria P. García-Pardo & Andrew C. Parrott. (2020) Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’). Brain Research 1727, pages 146556.
Crossref
Crossref
Madeline M. Pantoni & Stephan G. Anagnostaras. (2019) Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose. Pharmacological Reviews 71:3, pages 413-449.
Crossref
Crossref
Leopold Hermle & Felix Schuldt. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
551
565
.
Nicholas J. Connors & Robert S. Hoffman. 2017. Critical Care Toxicology. Critical Care Toxicology
1413
1438
.
Leopold Hermle & Felix Schuldt. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
20
.
Nicholas J. Connors & Robert S. Hoffman. 2016. Critical Care Toxicology. Critical Care Toxicology
1
26
.
Hadeel A. Alsufyani & James R. Docherty. (2015) Direct and indirect cardiovascular actions of cathinone and MDMA in the anaesthetized rat. European Journal of Pharmacology 758, pages 142-146.
Crossref
Crossref
J L Fitzgerald & J J Reid. (1994) Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Rabbit Isolated Cardiovascular Tissues. Journal of Pharmacy and Pharmacology 46:10, pages 826-832.
Crossref
Crossref
John C.M. Brust. (2010) Substance abuse and movement disorders. Movement Disorders 25:13, pages 2010-2020.
Crossref
Crossref
JR Docherty & AR Green. (2010) The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. British Journal of Pharmacology 160:5, pages 1029-1044.
Crossref
Crossref
Enno FreyeEnno Freye. 2010. Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs
161
172
.
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
129
170
.
Christopher D. Verrico, Gregory M. Miller & Bertha K. Madras. (2005) MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology 189:4, pages 489-503.
Crossref
Crossref
Sotiria Bexis & James R Docherty. (2006)
Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve
α
-adrenoceptors
. British Journal of Pharmacology 147:8, pages 926-934.
Crossref
Crossref
Robert G. Carlson, Jichuan Wang, Russel S. Falck & Harvey A. Siegal. (2005) Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug and Alcohol Dependence 79:2, pages 167-179.
Crossref
Crossref
Russel S Falck, Robert G Carlson, Jichuan Wang & Harvey A Siegal. (2004) Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence 74:1, pages 45-54.
Crossref
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
105
138
.
F. H. Zervogiannis, G. Bester & E. Wiechers. (2003) The “E” in Rave: A Profile of Young Ecstasy (MDMA) Users. South African Journal of Psychology 33:3, pages 162-169.
Crossref
Crossref
Linda Cleary & James R. Docherty. (2003) Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. European Journal of Pharmacology 476:1-2, pages 31-34.
Crossref
Crossref
J.C. Cole & H.R. Sumnall. (2003) Altered states: the clinical effects of Ecstasy. Pharmacology & Therapeutics 98:1, pages 35-58.
Crossref
Crossref
Maristela Ferigolo, Adriana G. da S. Machado, Niara B. Oliveira & Helena M. T. Barros. (2003) Ecstasy intoxication: the toxicological basis for treatment. Revista do Hospital das Clínicas 58:6, pages 332-341.
Crossref
Crossref
Catherine Vandeputte & James R Docherty. (2002) Vascular actions of 3,4-methylenedioxymethamphetamine in α2A/D-adrenoceptor knockout mice. European Journal of Pharmacology 457:1, pages 45-49.
Crossref
Crossref
George S. YacoubianJr.Jr.. (2002) Assessing the Temporal Relationship between Race and Ecstasy Use among High School Seniors. Journal of Drug Education 32:3, pages 213-225.
Crossref
Crossref
Linda Cleary, Robert Buber & James R Docherty. (2002) Effects of amphetamine derivatives and cathinone on noradrenaline-evoked contractions of rat right ventricle. European Journal of Pharmacology 451:3, pages 303-308.
Crossref
Crossref
J. Cabrera Forneiro. (2002) Ante un cambio, una respuesta: drogas de síntesis en España. FMC - Formación Médica Continuada en Atención Primaria 9:7, pages 514-523.
Crossref
Crossref
James E.J. Murphy, James J. Flynn, Dara M. Cannon, Patrick J. Guiry, Peter McCormack, Alan W. Baird, Gethin J. McBean & Alan K. Keenan. (2002) In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology 444:1-2, pages 61-67.
Crossref
Crossref
Kevin C. Osterhoudt. (2002) Experiencing Ecstasy: Is it all the Rave?. Pediatric Case Reviews 2:2, pages 126-129.
Crossref
Crossref
Christian J. Teter & Sally K. Guthrie. (2012) A Comprehensive Review of MDMA and GHB: Two Common Club Drugs. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21:12, pages 1486-1513.
Crossref
Crossref
Dara M Cannon, Alan K Keenan, Patrick J Guiry, Christophe Buon, Alan W Baird & Gethin J McBean. (2001)
In vitro
neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA
. British Journal of Pharmacology 134:7, pages 1455-1460.
Crossref
Crossref
John McDaid & James R Docherty. (2009)
Vascular actions of MDMA involve α
1
and α
2
‐adrenoceptors in the anaesthetized rat
. British Journal of Pharmacology 133:3, pages 429-437.
Crossref
Crossref
Wissam Al-Sahli, Husaimah Ahmad, Farhad Kheradmand, Claire Connolly & James R Docherty. (2001) Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery. European Journal of Pharmacology 422:1-3, pages 169-174.
Crossref
Crossref
MICHAEL SHANNON. (2000) Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatric Emergency Care 16:5, pages 377-380.
Crossref
Crossref
Aisling Lavelle, Valerie Honner & J R Docherty. (2009)
Investigation of the prejunctional α
2
‐adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
. British Journal of Pharmacology 128:5, pages 975-980.
Crossref
Crossref
Libby Topp, Julie Hando, Paul Dillon, Ann Roche & Nadia Solowij. (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug and Alcohol Dependence 55:1-2, pages 105-115.
Crossref
Crossref
A Walubo & D Seger. (2016) Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature. Human & Experimental Toxicology 18:2, pages 119-125.
Crossref
Crossref
Franz von Bruchhausen, Siegfried Ebel, Eberhard Hackenthal, Ulrike Holzgrabe, Margitta Albinus, Gudrun Amschler, Erwin von Angerer, C. Arras-Reiter, Andrea Bauer, Pia Bauer, Winfried Beil, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bossle, Franz Bracher, Helmut Bräunlich, Ellen Bretschneider, Regina Brigelius-Flohé, Kerstin Brinkmann, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Kurt Eger, Petra Eichhorn, Michael Engler, Thomas Erker, Peter Felfe, Alfred Fenyves, Reinhard Fescharek, Carmen Frackenpohl, August Wilhelm Frahm, Margarete Frahm, Volker Franke, Ulrich Franken, Detlef Geffken, Uli Geis, Erika Glusa, Berthold Göber, Peter Ndive Gobina, Werner Golder, Margarete Goppelt-Strübe, Katharina Götte, Erkme Gottstein, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Eberhard Heller, Dietrich von Herrath, J. Hilfenhaus, Ute Hoffmann-Schollmayer, Bernhard Hofmann, Christian Holpert, Ute Hübner-Steiner, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Hans Kemmler, Werner Kiefer, Christoph Klett, Stephanie Klett, Martin Klingmüller, Hans-Peter Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, M. Krüger, Markus Kuhn, Marion Sylvia Lehner, Detlef Leopoldt, Georg Liedtke, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Frank Peter Meyer, Wolfgang Meyerhof, Manfred Moos, Rudolf Morgenstern, Klaus Müller, Walter E. Müller, Corina Nachtsheim, Tilo Netzer, Michael Neugebauer, Werner Neupert, Peter Nickel, Peter Nuhn, Bernd Nürnberg, H. Oelschläger, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Rainer Pick, Martina Pickert, Andreas Pies, Eberhard Reimann, Joachim Richter, Kai Riecke, Suzanne Ritter, Hans Rommelspacher, Ulrich Rose, Gernot Roth, Gerhard Rücker, Judith Schäfer, Joachim G. Schantl, Helmut Schlager, Hildegard Schleinitz, Max Schmauß, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, B. Schneeweiß, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Johannes Schweiger, Gisela Skopp, Gisela Skorka, Kai Smolinka, Ulrich Speck, Ralf Stahlmann, Herbert Stein, Karlheinz Stiefvater, Karl-Heinz Surborg, Ulf Sürig, Hubert Szelényi, Istvan Szelenyi, Alfred Täufel, Ruth Thieroff-Ekerdt, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Sabine Vogel, Franz-Josef Volk, Thomas Vorwerk, Jürgen Wallmann, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Reinhold Wintersteiger, Frauke Woltmann, Beate Wüst, G. Zilow & A. Kluge. 1999. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
71
233
.
Maristela Ferigolo, Fernanda B. Medeiros & Helena M. T. Barros. (1998) "Êxtase": revisão farmacológica. Revista de Saúde Pública 32:5, pages 487-495.
Crossref
Crossref
Karel Valter & Philippe Arrizabalaga. 1998. Designer Drugs Directory. Designer Drugs Directory
17
18
.
Joseph A. Barone & Kenneth M. ShermockJRJR. (2016) Designer Drugs of Abuse. Journal of Pharmacy Practice 10:4, pages 292-300.
Crossref
Crossref
Richard S. Cohen & James Cocores. (1997) Neuropsychiatric manifestations following the use of 3, 4-methylenedioxymethamphetamine (MDMA; “Ecstasy”). Progress in Neuro-Psychopharmacology and Biological Psychiatry 21:4, pages 727-734.
Crossref
Crossref
Carrie Elk. (1996) MDMA (Ecstacy): Useful Information for Health Professionals Involved in Drug Education Programs. Journal of Drug Education 26:4, pages 349-356.
Crossref
Crossref
Richard S. Cohen. (1996) Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; “Ecstasy”). Biological Psychiatry 39:9, pages 819-820.
Crossref
Crossref
Richard S. Cohen. (1995) Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19:7, pages 1137-1145.
Crossref
Crossref
Philip K. Mcguire, Helen Cope & Thomas A. Fahy. (2018) Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’). British Journal of Psychiatry 165:3, pages 391-395.
Crossref
Crossref
Norman S Miller & Mark S Gold. (1994) LSD and Ecstasy: Pharmacology, Phenomenology, and Treatment. Psychiatric Annals 24:3, pages 131-133.
Crossref
Crossref
Hugh Series, Sietske Boeles, Eluned Dorkins & Robert Peveler. (2016) Psychiatric complications of 'Ecstasy' use. Journal of Psychopharmacology 8:1, pages 60-61.
Crossref
Crossref
J. D. WATSON, C. FERGUSON, C. J. HINDS, R. SKINNER & J. H. COAKLEY. (2007) Exertional heat stroke induced by amphetamine analogues. Anaesthesia 48:12, pages 1057-1060.
Crossref
Crossref
C. Jones. (1993) MDMA: The doubts surrounding Ecstasy and the response of the emergency nurse. Accident and Emergency Nursing 1:4, pages 193-198.
Crossref
Crossref
R.J. Renton, J.S. Cowie & M.C.H. Oon. (1993) A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis. Forensic Science International 60:3, pages 189-202.
Crossref
Crossref
B. TEHAN, R. HARDERN & A. BODENHAM. (1993) Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve'). Anaesthesia 48:6, pages 507-510.
Crossref
Crossref
Madeline Uddo, Robert M. Malow & Patricia B. Sutker. 1993. Comprehensive Handbook of Psychopathology. Comprehensive Handbook of Psychopathology
477
503
.
NADIA SOLOWIJ, WAYNE HALL & NICOLE LEE. (2010) Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug. British Journal of Addiction 87:8, pages 1161-1172.
Crossref
Crossref
James F. Buchanan, Howard E. McKinneyJr.Jr., Gregory N. Hayner & Darryl S. Inaba. 1992. Applied Therapeutics. Applied Therapeutics
1145
1173
.
J G Thorpe-Beeston, K H Nicolaides, D L Ewins, C M Gosden & A M McGregor. (1991) Thyroid function in fetuses with chromosomal abnormalities: Authors' reply. BMJ 302:6785, pages 1151-1152.
Crossref
Crossref
A R Winstock. (1991) Chronic paranoid psychosis after misuse of MDMA.. BMJ 302:6785, pages 1150-1151.
Crossref
Crossref
Katherine M. Hurlbut. (1991) Drug-Induced Psychoses. Emergency Medicine Clinics of North America 9:1, pages 31-52.
Crossref
Crossref
Norman S. MillerNorman S. Miller. 1991. The Pharmacology of Alcohol and Drugs of Abuse and Addiction. The Pharmacology of Alcohol and Drugs of Abuse and Addiction
173
183
.
Graeme P. Dowling. 1990. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA
63
75
.
George R. Greer & Requa Tolbert. 1990. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA
21
35
.
Alexander T. Shulgin. 1990. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA
1
20
.
G. Wilkerson & Edythe D. London. (1989) Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology 28:10, pages 1129-1138.
Crossref
Crossref
Jean-Marc Fritschy, W. Ernest Lyons, Mark E. Molliver & Reinhard Grzanna. (1988) Neurotoxic effects of p-chloroamphetamine on the serotoninergic innervation of the trigeminal motor nucleus: a retrograde transport study. Brain Research 473:2, pages 261-270.
Crossref
Crossref
Richard A. Glennon, Mamoun Yousif & Graham Patrick. (1988) Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacology Biochemistry and Behavior 29:3, pages 443-449.
Crossref
Crossref
James F. Buchanan & Christopher R. Brown. (2012) ‘Designer Drugs’. Medical Toxicology 3:1, pages 1-17.
Crossref
Crossref